Diphosphoinositol phosphates are a subclass of inositol phosphates possessing one or two high energy diphosphate groups instead of phosphoester substituents of the myo -inositol. Here we describe the enzymes responsible for their synthesis and degradation and how these may be regulated. Formation of diphosphoinositol phosphates in yeast and mammals is driven by an increase of the cellular energy charge, a lack of inorganic phosphate, and in mammals by osmotic or heat stress and in some cases by receptor mediated signaling. Known cellular actions are an improvement of the cell homeostasis by a reduction of the energy charge, increased phosphate uptake, improvement of mitochondrial performance, and an increase of insulin secretion in mammals. The underlying molecular mechanisms of action are far from being clarifi ed but an increasing body of knowledge about molecular details has highlighted their complex participation in many cellular systems and metabolic processes.
Introduction
Johann Joseph Scherer, a German medical scientist extracted a new type of sugar-like compound from muscle tissue in 1850. He identifi ed its elementary composition and named this novel compound ' Inosit ' (Scherer , 1850 ) . He had thus discovered myo -inositol, one of the nine possible inositol isomeric isoforms and the most abundant one in nature. The other isomers are cis -, epi -, allo -, muco -, neo -, d -chiro ( + )-, l -chiro (-)-and scyllo -inositol, with only the latter three of greater natural abundance. Except for the enantiomeric chiroinositol all other isomers are mesomeric forms.
Before continuing with a little history of the discovery of phosphorylated inositols, the reader should fi rst become familiar with the somewhat complex nomenclature of these derivatives. All inositols are cyclohexanehexol ring systems which only differ in hydroxyl confi guration. Myo -inositol in the favored chair conformation contains fi ve alternating equatorial and one single axial hydroxyl moieties (assigned to position 2). This isomerism of the molecule is responsible for an internal mirror symmetry where the mirror plane contains the 2-and the 5-hydroxyl C-O bonds and stands perpendicular to the six-ring normally with a chair conformation ( Figure 1 ). This particular structure, when carrying substituents of the ring hydroxyls, gives rise to a large set of enantiomeric and mesomeric derivatives. In nature, the hydroxyl groups are rather often substituted by phosphoric acid esters. Mathematically, 63 different isomers of inositol phosphates (InsPs) containing 1 -6 phosphates with 24 enantiomeric pairs and 15 meso -forms are predictable (Table 1 ) . Not all of them but a majority has been shown to be of biological relevance. To denote precisely the different phosphorylated isomers or their enantiomers, a special ' relaxed IUPAC rule ' for notation of the substituted positions has been suggested (NC -IUB, 1989 ) . For example, in d -myo Ins(1,4,5)P 3 , three phosphates are located at positions 1, 4, and 5 of the myo -inositol ring making the structure enantiomeric. The relaxed rule for numbering of substituted inositols goes back to Agranoff ' s proposal to use a ' turtle with head up ' (Agranoff , 1978 ) to represent the inositol ring where the right forelimb is assigned to 1-, the head to 2-position, and, by moving counterclockwise around the turtle ' s limbs, the tail is at the 5-position. Before Agranoff ' s recommendation in 1988 to use only this inositol ring d -notation for all myo -inositol phosphates, they were designated according to the standard IUPAC rules for carbohydrates with the d / l -notation for pairs of enantiomers following the ' lowest number rule ' (NC -IUB, 1989 ) . Inositol is three letter-coded as ' Ins ' , but the one letter notation ' I ' should not be used due to confusion with the oddly coded nucleoside inosine (I) containing the base hypoxanthin (I). Using Agranoff ' s rule, e.g., the recently discovered doubly pyrophosphorylated myo -InsP 6 derivative d -myo -1,5PP 2 -InsP 4 is the enantiomer of d -3,5PP 2 -InsP 4 which according to standard IUPAC rules should be designated l -myo -1,5PP 2 -InsP 4 (Figure 1 ). Although the latter nomenclature appears logical, standard IUPAC rules often led to the situation where metabolic addition or removal of one single phosphate to inositol phosphates switched the enantiomeric designation from d -to l -forms or vice versa which caused confusion to non-specialists in the fi eld and are mainly omitted to date. In the above structures derived from InsP 6 , the full ' Agranoff notation ' is redundant for the positions of unsubstituted phosphate groups, which therefore are also omitted. However, the full notation of all phosphates in addition to pyrophosphates in fact is necessary for an InsP x derivative with x < 6. Because most biological inositol phosphates are derived from my oinositol, and the d -notion is generally used, the compound depicted in Figure 1 is normally just designated 1,5PP 2 -InsP 4 . This isomer is one of the 15 theoretically possible isomers of the PP 2 -InsP 4 . Now taking myo-InsP 6 instead of myo -inositol as the basic ring structure, again the numbers in Table 1 are valid for theoretical isomer numbers. Although at present there is no indication of as many inositol pyrophosphate isomers as isomers of inositol phosphates in vivo , inositol phosphate research has also started with a fairly low number of isomers.
The name ' inositol poly phosphates ' for non-pyrophosphorylated inositol phosphates is also misleading because the term polyphosphate in other organic or inorganic phosphates denotes linear (or cyclic) anhydride bonded chains of phosphates ( > 2), e.g., in di-adenosine polyphosphates. A still correct general name is ' inositol phosphates ' . The full name nomenclature correctly denotes the number of individual phosphoester links at the ring by the prefi xes bis-, P P la n e o f s y m m e tr y P P P P P P P P P P P P P P P P P P P P P P P On the left, myo -inositol is shown with its plane of mirror symmetry dividing the ring into two symmetrical halves. The mirror symmetrical positions are highlighted in red (1 and 3; 4 and 6). d -myo -1,5PP 2 -Ins(2,3,4,6)P 4 and d -myo -3,5PP 2 -Ins(1,2,4,6)P 4 , denoted according to the relaxed IUPAC nomenclature behave like image and mirror image, i.e., represent a pair of enantiomers. d -myo -3,5PP 2 -Ins(1,2,4,6)P 4 (relaxed IUPAC nomenclature; IUPAC -IUB, 1989 ) and l -myo -1,5PP 2 -Ins(2,3,4,6)P 4 (standard IUPAC terminology for carbohydrates) denote one identical structure. (Picture/structures produced with ACD /ChemSketch, 2012 .) tris-, tetrakis-, pentakis-and hexakis-put before phosphate. For pyrophosphorylated inositol phosphates, the best group name would be ' diphosphoinositol phosphates ' or ' pyrophosphoinositol phosphates ' , because ' inositol pyrophosphates ' implies no further normal phosphoester groups in the compounds, which, however, are always present in addition to pyrophosphates. In this review, we will from here on use the former name for any of these compounds and as an abbreviation ' DPIP ' . To revisit the history of inositol phosphates, it was at the beginning of the 20th century, when a few groups of mainly carbohydrate researchers were engaged with inositols and inositol phosphates. However, in subsequent decades this research topic almost vanished from the scene. Many years later, in the 1980s, came a marked breakthrough. Inositol-1,4,5-trisphosphate, Ins(1,4,5)P 3 , was identifi ed as a phosphoinositide derived second messenger that regulates the release of Ca 2 + from intracellular stores . This fi nding was the fi rst to show the great importance of inositol phosphates not only to the few established inositol phosphate and phosphoinositide researchers but also the broad scientifi c community. In the following years, an expanded number of further inositol phosphate isomers were identifi ed whose functions have been more or less characterized so far. The spectrum of soluble inositols ranges from unphosphorylated myo -inositol to the fully phosphorylated inositol hexakisphosphate (also named phytic acid or la phytine by its French discoverers in plants) and beyond (see review by Irvine and Schell , 2001 ) .
Since the discovery of the pyrophosphorylated inositol phosphates PP-InsP 5 and PP 2 -InsP 4 and their underlying structures in 1992 in Dictyostelium (Mayr et al. , 1992 ) and also in animal cells (Menniti et al. , 1993 ; Stephens et al. , 1993 ) , these high energy inositol phosphates again merged slowly into scientifi c focus. The term high energy inositol phosphates is based on its single or double pyrophosphate groups containing one or two high energy phosphoanhydride bonds. Similar diphosphate groups are bound to the ribose 5-hydroxyl in ADP or to its 1-hydroxyl in 5-phosphoribosyl-1-pyrophosphate (PRPP). Whereas the predicted phosphoester (C-O-P) bond energy between the inositol ring and the α phosphate of the diphosphate group is approximately 14 kJ/mol, the predicted energy of the phosphoanhydride bond (P-O-P) is approximately 28 kJ/mol. This is slightly higher than the measured hydrolysis standard enthalpy of ADP but lower than that of the outer anhydride bond of ATP. However, owing to the fact that PP 2 -InsP 4 possesses two of these phosphoanhydride bonds and steric interference and charge repulsion by the neighboring phosphate groups, hydrolysis may in reality be still much easier (Laussmann et al. , 1996 ; Hand and Honek , 2007 ) .
Most of the natural diphosphoinositol phosphates (DPIPs) identifi ed so far in the fungi-metazoa group of organisms derive from InsP 6 or the most abundant vertebrate InsP 5 isomer, Ins(1,3,4,5,6)P 5 . The best-studied and most abundant InsP 6 derived DPIPs are 5PP-InsP 5 and 1PP-InsP 5 for the InsP 7 group of isomers and 1,5PP 2 -InsP 4 as the major PP 2 -InsP 4 isomer. The full unequivocal naming of the latter compound is 1,5-bis-diphospho-inositol tetrakisphosphate. Draskovic et al. (2008) identifi ed the isomeric nature of the PP-InsP 4 derivative synthesized by IP6Ks as 5PP-InsP 4 or a mixture (80/20) of 1/3PP-InsP 4 and 5PP-InsP 4 , depending on the utilized buffer conditions (Draskovic et al. , 2008 ) . To avoid confusion about the notation of the Ins(1,3,4,5,6)P 5 derived mono-and bis-pyrophosphates, we will designate them as PP-InsP 4 or PP 2 -InsP 3 without further positional specifi cation.
5PP-InsP 5 may amount between 0.5 and 1.3 μ m in mammalian cells (Table 2 ) and in yeast, whereas in Dictyostelium its concentration reaches a higher range (Mayr et al. , 1992 ; Stephens et al. , 1993 ; Albert et al. , 1997 ; Laussmann et al. , 2000 ) . 1PP-InsP 5 is the minor of the two mammalian and yeast PP-InsP 5 isomers and 1,5PP 2 -InsP 4 maximally reaches approximately 10 -20 % of the cellular concentration of PP-InsP 5 under fl uoride inhibition of phosphatases (Albert et al. , 1997 ) . In the slime mold forming protozoa Dictostelium and Polyspondilium , PP-InsP 5 and PP 2 -InsP 4 isomers with the structures 6PP-InsP 5 and 5,6PP 2 -InsP 4 are predominating in up to millimolar concentration and probably serve, in fact, as high energy stores in multicellular and spore building stages of these organisms (Albert et al. , 1997 ; Laussmann et al. , 2000 ) .
Diphosphoinositol phosphate generating kinases and degrading phosphatases
Biosynthesis and degradation of DPIPs from InsP 6 and Ins(1,3,4,5,6)P 5 in vertebrates and yeast is maintained by kinases and phosphatases which succumb a cycling turnover between the pyrophosphorylated and the non-pyrophosphorylated parent structures. To date, only two major kinase classes (with several paralogous class members) are known to be responsible for biosynthesis, whereas only one class of phosphatases is presently known to hydrolyze the pyrophosphate moieties of these compounds. The mammalian IP6Ks (Isoforms 1, 2, and 3) or their single ortholog from yeast, named Kcs1, belong to the PDKG kinase superfamily of inositol phosphate kinases (Gonzalez et al. , 2004 ) , which upon BLAST and structural homology searches show a distant resemblance in some catalytic domain sequence motifs and in 3D structure to PKC and some atypical protein kinases. They transfer the γ -phosphate from ATP detectably to the 5 phosphate of Ins(1,3,4,5,6)P 5 or InsP 6 generating either 5PP-Ins(1,3,4,6)P 4 or 5PP-InsP 5 (Voglmaier et al. , 1996 ; Albert et al. , 1997 ; Saiardi et al. , 1999 Saiardi et al. , , 2001 Draskovic et al. , 2008 ) . Note that 5PP-InsP 4 , in principle, could also be formed from four other isomers of InsP 5 that contain the 5-phosphate. Whether some of these ' minor ' cellular InsP 5 isomers are also pyrophosphorylated in vivo is not known yet.
The second kinase class represents a completely novel family of substrate kinases. They were fi rst identifi ed and cloned by the York laboratory as Vip1 in yeast, whereas the two cloned mammalian homologs were designated PPIP5K1 and PPIP5K2, respectively Mulugu et al. , 2007 ) . These enzymes convert InsP 6 to a second PP-InsP 5 isomer that possesses a pyrophosphate at the 1 position (Lin et al. , 2009 ; Wang et al. , 2011 ) . The clarifi cation of the isomeric structure had been challenging. Owing to a fi rst nuclear magnetic resonance (NMR) analysis it was designated to be one or both of the enantiomeric pair 4-or 6PP-InsP 5 (Lee et al. , 2007 (Lee et al. , , 2008b . Later it was proven that the product is 1-or 3PP-InsP 5 (Lin et al. , 2009 ). In the latter study employing metal-dye-detection (MDD)-HPLC, a method for seperation of non-radioactive Inositolphosphate Compounds, (Mayr , 1988 ; Mayr et al. , 1992 ) and NMR characterized reference compounds for isomeric product assignment, we could also show that the PP 2 -InsP 4 isomer generated from 5PP-InsP 5 is also pyrophosphorylated either at position 1 or 3. Because enantiomeric pairs cannot be discriminated by anion exchange HPLC or NMR analysis, respectively, it was impossible to resolve the true enantiomeric structure. However, in a recent impressive crystallization study on the PPIP5K2 3D structure done by Wang together with the Shear group employing enantioselectively synthesized PP-InsP 5 isomers from the Falck laboratory, the 3D structure of the catalytic domain with bound substrates and products could be resolved to atomic resolution. The authors demonstrated not only that the resulting product made from InsP 6 is 1PP-InsP 5 and not 3PP-InsP 5 but also demonstrated small scale details of how the γ -phosphate of ATP is site specifi cally transferred against the charge repulsion of the highly anionic InsP 6 molecule specifi cally to its 1-phosphate. Furthermore, they could demonstrate phosphate transfer from ATP to the 1-phosphate of 5PP-InsP 5 generating 1,5PP 2 -InsP 4 .
To summarize, Kcs1/IP6K are 5-kinases and Vip/PPIP5K are now known to be 1-kinases. Both are involved in the biosynthesis of the vertebrate and yeast 1,5PP 2 -InsP 4 . Each PP-InsP 5 product made by either kinase serves as a substrate for the other kinase. The two pathway system from InsP 6 to 1,5PP 2 -InsP 4 is depicted in the scheme of Figure 2 together with the more hypothetic analogous rhomb-shaped pathways starting from Ins(1,3,4,5,6)P 5 . Because in vivo 5PP-InsP 5 is the dominant PP-InsP 5 , it is likely that 5-pyrophosphorylation is the preferred fi rst step, i.e., the paths on the right site of the rhombs are the preferred ones. The enzymatic properties of these kinases are compiled in Tables 3 and 4 . Both enzymes have a low abundance in yeast and mammalian cells enabling them only to synthesize submicromolar concentrations of products within minutes. This renders them unlikely to contribute in phasic receptor-mediated signaling events. An average cell volume of 2.5 pl was taken and the cytoplasmic plus nucleosolic volume was assumed as 70 % of total.
e An average cell volume of 1 pl (instead of 0.5 pl for the single cell volume) was taken to account for frequent cell clusters and the cytoplasmic plus nucleosolic volume was taken as 70 % of total.
f InsP 8 after fl uoride inhibition was estimated from an average fraction of 17 % of the built 5PP-InsP 5 which was derived from the analyses of three cell lines (H1299, NIH-3T3, and MDA) by Lin et al. (2009) after the same fl uoride treatment. g Values are below the detection limit which is given.n.d., not determined.
To obtain a more detailed insight into the functions of the enzymes please refer to Barker et al. (2009) and Chakraborty et al. (2011) .
Phosphatases able to catalyze the reverse of these kinase reactions by hydrolyzing the pyrophosphate groups are MIPP (multiple inositol polyphosphate phosphatase) Craxton et al. , 1997 ) and the isoforms of DIPP (diphosphoinositol phosphate phosphohydrolase) fi rst discovered by . MIPP has been shown to hydrolyze the 5 β -phosphates in vitro. Owing to its location in the endoplasmic reticulum and therefore physical separation from its substrates it seems not to hydrolyze DPIPs in vivo (Ali et al. , 1993 ) . The fi ve human DIPP isoforms 1, 2 α , 2 β , 3 α , 3 β , and the single yeast orthologs Ddp1 ( Saccharomyces cerevisiae ) and Aps1 ( Schizosaccharomyces pombe ) (Safrany et al. , 1999 ; Hidaka et al. , 2002 ; Leslie et al. , 2002 ) are members of the large family of Nudix hydrolases comprising up to 100 genes and pseudogenes in humans. In general, Nudix hydrolases catalyze the anhydride bond cleavage in substrates of the form nu cleoside di phosphate linked to some other moiety, X. However, nucleosides are not necessary for hydrolysis of an attached diphosphate moiety (McLennan , 2006 ) . The DIPP subfamily is an example of Nudix hydrolases being able to cleave the β -phosphate of DPIPs containing no AMP . The DIPPs hydrolyze their substrates in a site-specifi c order. In 1,5PP 2 -InsP 4 they prefer the position 1 which is hydrolyzed fi rst, followed by position 5 . One can speculate whether DIPPs have the same preferred pyrophosphates in InsP 5 derived PP 2 -InsP 3 . To be fully active, DIPPs need a free Mg 2 + of 1.5 -2 m m . InsP 6 is no suitable substrate but still binds strongly to DIPPs acting as an inhibitor with IC 50 values of 3 μ m and 0.2 μ m with respect to PP-InsP 5 and for PP 2 -InsP 4 as substrates (Safrany et al. , 1999 ) . The high amount of InsP 6 in cells and the high cellular activity of several DIPPs could account for the high observed degree of inositol pyrophosphate cycling where 50 % of the previously steady-state labeled InsP 6 pool is cycling through the pyrophosphate states every hour (Glennon and Shears , 1993 ; Menniti et al. , 1993 ) . All DIPP isoforms are rather small, probably diffusible proteins of approximately 20 kDa and contain ' Mut-T modules ' important in recognition of normal or oxidized purine nucleotides. Mutation of this module also abolishes inositol pyrophosphatase activity . The K m values of hDIPP1 and the two hDIPP2 forms for 5PP-InsP 5 are all around 4.5 n m , for the DIPP3 isoforms they are 1300 -4000 n m (Leslie et al. , 2002 ) or 53 -88 n m (Hidaka et al. , 2002 ) , respectively, and for both yeast orthologs they are 31 n m (Safrany et al. , 1999 ) . The fact that fl uoride inhibits all DIPPs with a K i value of approximately/below 10 μ m explains the dramatic radioactive label increases (Glennon and Shears , 1993 ; Menniti et al. , 1993 ) and also mass increases of 5PP-InsP 5 and 1,5PP 2 -InsP 4 upon fl uoride treatment of cells (Albert et al. , 1997 ; Lin et al. , 2009 ;  Table 2 ). When using Tritium prelabeling of cellular inositol, Shears et al. (1995) and Ho Ho P Ho P P P P P P P P P P P P P P P P P P and of likely the molecule 1,5PP 2 -Ins(3,4,6)P 3 can be brought about by fi rst employing IP6K/Kcs to synthesize the 5-PP derivative and then PPIP5K/Vip to add the 1PP group or vice versa. Thus, two bifurcated ' diamond shaped ' reaction paths lead to the bispyrophosphates derived from InsP 6 and Ins(1,3,4,5,6)P 5 , respectively. The structures of 1PP-Ins(3,4,5,6)P 4 as well as 1,5PP 2 -Ins(3,4,6)P 3 are marked with an interrogation mark, because the structures have not been determined yet and are only tentative. This pathway is based on our own unpublished data.
Regulation of cellular amounts and changes of diphosphoinositol phosphate concentrations
Do these enzymatic data explain the cellular situation ? For the 2-h period of maximal formation of DPIPs due to complete inhibition of dephosphorylating DIPP enzymes in the experiments of Albert et al. (1997) and Lin et al. (2009) , maximal rates of cellular formation of ≥ 70 n m /min and 16 n m /min can be derived by mass analyses for 5PP-InsP 5 and 1,5PP 2 -InsP 4 , respectively. For the maximal formation of 1PP-InsP 5 from InsP 6 , approximately 7 n m /min can be derived. Assuming 50 % cycling between InsP 6 and 5PP-InsP 5 within 1 h derived from radioactive prelabeling experiments (see above) and an exchangeable cellular InsP 6 of 10 μ m , a rate of 166 n m /min can be derived for 5PP-InsP 5 production. These two independent estimates for formation of PP-InsP 5 are in good agreement. Taking the specifi c activity of the ubiquitously expressed IP6K1 for InsP 6 of 310 nmol/min/mg from Table 4 results in a k cat value of 18 min. This implies that 5 -10 n m IP6K1 and in many cells a similar activity of IP6K2 is present in the cell. Owing to the much lower specifi c activity of PPIP5K and its 10-fold lower observed maximal cellular activity against InsP 6 (see above), it is clear that 5PP-InsP 5 is the dominating cellular PP-InsP 5 . From the purifi cation table of for DIPP from rat liver, we can also estimate maximal cellular DIPP activity. In the initial homogenate, the specifi c activities for PP-InsP 5 and PP 2 -InsP 4 dephosphorylation were approximately 0.0025 and 0.0008 in nmol/min/mg protein.
Assuming a 40 % cytosolic volume of whole liver tissue this was converted into a maximal cytosolic activity of 2100 n m /min for PP-InsP 5 and 700 n m /min for PP 2 -InsP 4 . This should be brought about by ∼ 200 n m of DIPP enzymes based on data of Caffrey et al. (2000) and Hidaka et al. (2002) i.e., a 10-to 40-fold higher cellular concentration of these enzymes than of IP6K. Together with the extremely low K m values of DIPP1, DIPP2 α and DIPP2 β for PP-InsP 5 of approximately 5 n m , it appears that all 5PP-InsP 5 formed in cells is immediately degraded again. However, showed that InsP 6 is a fairly potent inhibitor of the DIPP enzymes with IC 50 values of 3 μ m and 0.2 μ m with respect to PP-InsP 5 and for PP 2 -InsP 4 as substrates. Taking the cellular InsP 6 concentrations of 10 -100 μ m (Table 2) into account and assuming a ∼ 50 % soluble fraction thereof, the DIPP activities would be strongly reduced by soluble InsP 6 to between approximately 2 % and 15 % of the uninhibited activities, respectively, now allowing, in fact, the observed cellular phosphorylation-dephosphorylation equilibrium concentrations of 5PP-InsP 5 (Table 4) to establish. The absence of detectable 1PP-InsP 5 without fl uoride inhibition of DIPPs is just the consequence of the 10-fold lower maximal cellular rate of formation of this isomer. The DIPPs probably binding this isomer, similar to PP-InsP 5 , will bring the equilibrium to a very low level. Intriguingly, both the kinases and the phosphatases involved have such high affi nities for their respective substrates, InsP 6 and PP-InsP 5 , that the equilibrium appears to be purely velocity controlled, i.e., purely by the cellular amounts of both (probably V max -regulated) enzymes. Another situation exists for the formation of 1,5PP 2 -InsP 4 from 5PP-InsP 5 . Clearly this reaction is affi nity controlled. The K m of PPIP5K for 5PP-InsP 5 determined in vitro to be 0.1 μ m (Table 4) is really increased in cells due to the competition by 20-to 100-fold more InsP 6 as an alternative substrate (see Table 4 ). Assuming competitive inhibition, this will dramatically increase the apparent K m value of PPIP5K/ Vip for 5PP-InsP 5 to above 1 μ m . Thus, the observed cellular concentrations of 5PP-InsP 5 between 0.5 and 1.3 μ m (Table 2) are probably controlling 1,5PP 2 -InsP 4 formation. Again, free InsP 6 appears to be a critical controller in this reaction. Although free InsP 6 may thus be an important cellular determinant of the steady-state concentrations of 1,5PP 2 -InsP 4 , it is likely from the low concentrations of 1,5PP 2 -InsP 4 and 1PP-InsP 5 ( Table 2 ) that only a subcellular focused production of PP-InsP 5 and PP 2 -InsP 4 or inhibition of DIPPs would lead to local increases of the compounds over the 30 -70 nanomolar level (our detection limits for these compounds, Table 2 ).
Diphosphoinositol phosphate made from InsP 5 (PP-InsP 4 ) inhibits DNA damage repair and induces telomere shortening
Ins(1,3,4,5,6)P 5 is the second most abundant inositol phosphate in mammalian cells (Shears , 1998 ) and in yeast. It is not only the metabolic precursor of InsP 6 but can also be pyrophosphorylated by the yeast Kcs1 or mammalian IP6K to a PP-InsP 4 (Saiardi et al. , 2000 ) . Its identifi cation was brought about by a series of mutant yeast strains with a selective depletion of the IP5-2-kinase (IPK1) and Kcs1, two enzymes that are indirectly or directly responsible for the formation of PP-InsP 4 ( ipk1 Δ and kcs1 Δ ) (Saiardi et al. , 2005 ; York et al. , 2005 ) . Within a few months, the two groups identifi ed a physiological role for this DPIP (Saiardi et al. , 2005 ; York et al. , 2005 ) . The cellular availability of PP-InsP 4 correlated negatively with the length of telomeres which means that an increase of PP-InsP 4 triggered telomere shortening. York et al. (2005) identifi ed Tel1, a member of the phospho i nositide-3-kinase-related protein kinase (PIKK) family that is functionally associated with PP-InsP 4 . The PIKK family members comprising Tel1, Mec1, and Tor1/2 in yeast together with further proteins are responsible for recognition and signaling of DNA damage through their kinase activity and can form active rescue/repair complexes (for review see Hiom , 2005 ; Longhese , 2008 ; Shore and Bianchi , 2009 ; Dobbs et al. , 2010 ) . Depletion of Tel1 led to the same observed shortening of telomeres as an increase of PP-InsP 4 in wild-type (WT) strains. By contrast, an increase of PP-InsP 4 in a Tel1-depleted strain had no effect on the telomeres. They proposed a possible inhibition of Tel1 kinase activity by elevated PP-InsP 4 levels. Saiardi et al. (2005) confi rmed the effect of PP-InsP 4 on Tel1 and identifi ed one further member of the PIKK family, Mec1, which is also functionally associated with PP-InsP 4 . Although all their experiments, which were complemented by employing specifi c inhibitors, argued for an inhibition of Tel1 and Mec1 by PP-InsP 4 , Saiardi et al. (2005) wanted to substantiate the inhibitory effect of PP-InsP 4 on Mec1 by using a mec1 Δ strain. Unfortunately the depletion was lethal, also when combined with a depletion of SML1 to suppress lethality. They also investigated the infl uence of PP-InsP 4 on the third PIKK member in yeast, Tor1/2, by specifi c inhibition with rapamycin. However, rapamycin killed the strains and the inositol pyrophosphate levels did not correlate with rapamycin toxicity. They concluded that Tor1/2 is neither involved in the process regulated by PP-InsP 4 nor in the Tel1-and Mec1-mediated effects discussed above. However, they could not rule out that Tor1/2 effects might also depend on inositol pyrophosphate signaling.
In conclusion, at least two of the enzymes of the yeast PIKK family are inhibited by PP-InsP 4 with subsequent loss of DNA damage signaling and hence ineffective DNA repair or enhanced telomere shortening. Whether there is a similar mechanism dependent on PP-InsP 4 in vertebrate cells is unclear. The mammalian PIKK homologs are ATM ( a taxiat eleangiectasia m utated), ATR (ataxia t eleangiectasia mutated-related), DNA-PKcs (DNA-dependent protein kinase catalytic subunit), and mTOR ( m ammalian t arget of r apamycin). For DNA-PK, an activating effect of InsP 6 (Hanakahi , 2011 ) and a direct binding to the Ku proteins being associated with DNA-PK in a larger protein complex (Ma and Lieber , 2002 ) has been shown. The complex is engaged in DNA double-strand break repair by non-homologous end joining, in keeping breakage ends together with the help of InsP 6 , signaling the break, and also in telomere length regulation (Espejel et al. , 2002 ) . This opens the intriguing hypothesis of an antagonism between cellular InsP 6 stabilizing such complexes and the structurally different PP-InsP 4 (another InsP 6 isomer) inhibiting their formation. For this interplay, IPPK (IP5-2K, IPK1 in yeast) together with IP6K (Kcs1 in yeast) would be the participating players.
Signaling role of 1PP-InsP 5 in phosphate starvation: specifi c inhibition of the cyclin-dependent kinase Pho85 system 1PP-InsP 5 is synthesized from InsP 6 by the yeast kinase Vip1 or the mammalian PPIP5K1/2. The enzymes as well as this isomer are the latest discovered parts of the inositol pyrophosphate metabolic system (Figure 2) . In comparison to 5PP-InsP 5 it is the minor PP-InsP 5 isomer found in mammalian tissue (see above). Its biological action has been studied in yeast and one function is highly specifi c to a signaling pathway involved in phosphate starvation. That a linkage between phosphate metabolism and DPIPs does exist was not surprising. The fi rst discovered mammalian InsP 6 converting enzyme (IP6K2) was linked to phosphate uptake in Xenopus experiments and therefore named PiUS (inorganic phosphate uptake stimulator) (Norbis et al. , 1997 ) before it was discovered to be an IP6K (Schell et al. , 1999 ) , i.e., IP6K was quite early known to be functionally linked to P i uptake. What surprised the most in the fi ndings described next was the linkage of the Vip1/PPIP5K product 1PP-InsP 5 to phosphate metabolism and not 5PP-InsP 5 , the IP6K /Kcs1 product.
In response to phosphate starvation, yeast is able to transcribe phosphate-starvation-responsive genes (Springer et al. , 2003 ) . This response is tightly regulated by the Pho85 kinase, a cyclin-dependent kinase whose activity is controlled by ten different cyclins (Measday et al. , 1997 ) and which therefore is involved in several signaling pathways activated in response to environmental stresses. It participates in carbon utilization, glycogen metabolism, phosphate metabolism, morphogenesis, and cell cycle progression (for a review see Carroll and O ' Shea, 2002 ; Huang et al. , 2007 ) . This broad range of events regulated by Pho85 and the high specifi city of 1PP-InsP 5 in regulating Pho85 with respect to infl uences on the phosphatestarvation-response genes are in remarkable contrast.
Cyclin Pho80 association with Pho85 leads to a fully active Cdk complex (Kaffman et al. , 1994 ) . Pho85 also associates with its inhibitor Pho81, which under abundant phosphate conditions renders the ternary complex (Pho80-Pho85-Pho81) still active (Schneider et al. , 1994 ) . The transcription factor Pho4, when phosphorylated by Pho85, is predominantly re-exported from the nucleus to the cytoplasm and its response genes are not expressed. When inorganic phosphate becomes scarce, Pho81 fully inactivates the ternary complex. Pho4 now becomes dephosphorylated, translocates into the nucleus, and stimulates the expression of the phosphate-starvation-response genes such as Pho84, the high affi nity P i uptake transporter and Pho5, a repressible acid phosphatase involved in extracellular P i mobilization. How the inhibition of the active Pho80-Pho85-Pho81 complex is post-translationally brought about in response to a low intracellular P i or other events was an enigma until 2007. With a smart experimental approach, the O ' Shea laboratory identifi ed the PP-InsP 5 product of Vip1, which they erroneously ascribed to 4/6PP-InsP5, as an essential cofactor of the switch (Lee et al. , 2007 ) . They performed a Pho4 kinase assay as an indicator for the activity of the ternary complex and fractionated cellular extract from phosphate starved yeast for an activating effect on Pho4. Thereby, they identifi ed a PP-InsP 5 in the < 3 kDa fraction with the help of NMR and mass spectrometry (MS) analyses. Furthermore, they recognized an increase of this isomer during phosphate starvation and also showed that the product of Kcs1, 5PP-InsP 5 , cannot mimic this inhibitory effect. In a further study, Lee et al. (2008b) showed that the inhibition by the novel PP-InsP 5 isomer is allosteric and reversible. One likely mechanism of how PP-InsP 5 activates inhibition is that by binding to Pho81 it triggers a conformational change in the Pho85 Cdk which might shift the peptide binding site apart from the ATP binding site (Figure 3 ). In the studies by Lin et al. (2009) it was fi nally proven that 1/3PP-InsP 5 is the true isomeric product of Vip1 and thus an activating factor for the phosphate starvation response. But what may be the role of IP6K/Kcs1 in P i uptake stimulation ? First, also yeast lacking Kcs1 exhibited considerably reduced P i uptake (Saiardi et al. , 2004 ) . Second, Auesukaree et al. (2005) found that several enzymes lead to biosynthesis of 5PP-InsP 5 and 5PP-InsP 4 in yeast from Ins(1,4,5)P 3 (Plc1, Arg82/IPMK and Kcs1), in particular the last enzyme, Kcs1, is involved and necessary for negative control of PHO5 secretion (Auesukaree et al. , 2005 ) . Third, when using the SPELL databank in the yeast genome database ( www.yeastgenome.org ) to survey cell wide effects of phosphate starvation on yeast genes, we, in fact, found a very strong increase noted in Kcs1 (Brauer et al. , 2008 ) , which is also correlated with an increase in the P i transporter Pho84 (Ogawa et al. , 2000 ) . The most plausible conclusion from these additional fi ndings is that a further product requiring both Kcs1 and Vip1 but not being 5PP-InsP 5 (see above) is also an effector in the phosphate starvation response. Only 1,5PP 2 -InsP 4 , and the related InsP 5 derivative, 1,5PP 2 -Ins(3,4,6)P 3 , fulfi ll these conditions and are possible to be even better effectors of the discovered mechanism than 1PP-InsP 5 . This is a fi rst indication of cellular DPIP as a cell homeostasis regulator.
Because the IP6K2 fi rst designated PiUS was clearly linked functionally to P i uptake (Norbis et al. , 1997 ) , it seems likely that a system for P i homeostasis similar to that in yeast exists in vertebrates. A recent yeast study where a phosphate starvation-phosphate overplus protocol has been employed to analyze PP-InsP 5 and polyphosphate changes adds more intriguing data (Lonetti et al. , 2011 ) . Under phosphate starvation (1 h and 2 h) leading to a strong fall in the ATP level (Boer et al. , 2010 ) , they detected a parallel fall in the PP-InsP 5 /InsP 6 ratio. Whereas polyphosphate almost disappeared after 2 h, DPIPs only fell to a certain level but did not disappear. Intriguingly, in a vip1 Δ strain also employed, an increase in the PP-InsP 5 /InsP 6 ratio by a factor of 3 in normal culture condition was observed which directs towards a negative contribution of Vip1 to the level of 5PP-InsP 5 , possibly due to formation of the above-mentioned alternative Vip1 products.
Elevated levels of PP 2 -InsP 4 in response to hyperosmotic and thermal stress in mammalian cells are not classical signaling results
Long before the isolation or cloning of the second inositol pyrophosphate synthesizing enzyme PPIP5K (Choi et al. , 2007 ; Fridy et al. , 2007 ) , which is indispensable for the formation of 1,5-PP 2 -InsP 4 (Figure 2) , Safrany (2004) identifi ed a range of conditions and drugs that affect DPIP levels among them hyperosmotic conditions and drugs also lowering cellular ATP levels (Safrany , 2004 ) . At the same time, the Shears laboratory, searching for signaling conditions stimulating the biosynthesis of DPIPs, described a stimulation of PP 2 -InsP 4 levels by hyperosmotic stress (Pesesse et al. , 2004 ) . They treated human embryonic kidney (HEK) cells and Syrian hamster vas deferens smooth muscle cells (DDT 1 MF-2) with 0.2 m sorbitol and, within 5 -10 min after treatment, they observed a 10-to 25-fold increase of the PP 2 -[ 3 H]InsP 4 after prelabeling the cells with [ 3 H]-myo -inositol to steady state. By using either different sorbitol concentrations or several inhibitors for perturbation of the JNK/MAP or ERK/ p38 MAP kinase pathways, they wanted to ascertain whether one of the three MAP kinase pathways is involved in changing PP 2 -InsP 4 production but could not ascertain such dependence. However, the inhibitors used in the study (PD098059 or U0126) for the ERK/p38 MAP kinase pathway had another distinct infl uence on cells that was not known at that time: they change the energy status of cells by raising the AMP to ATP ratio (Yung et al. , 2004 ; Dokladda et al. , 2005 ) . Choi et al. (2008) verifi ed this effect of the two inhibitors on the cellular energy balance and showed that these and a third inhibitor (PD184352) inhibit AMPK (AMP-activated protein kinase), which is a very sensitive sensor for an increase of cellular AMP, a metabolite activating many metabolic systems suitable to restore the cellular energy balance. Its inhibition thus keeps the AMP level high. At that stage of research, it became clear that no MAP kinase pathway is involved in PP 2 -InsP 4 biosynthesis due to osmotic stress but in fact just the energy charge is positively correlated with the potential of cells to synthesize PP 2 -InsP 4 . Choi et al. (2005) also checked whether other types of cellular challenges such as mechanic, thermal, and oxidative stress also result in elevated PP 2 -InsP 4 levels. Although they showed activation of ERK and slightly of p38 due to mechanical and oxidative stress, PP 2 -InsP 4 levels were unaffected. This confi rms the supposed independence of PP 2 -InsP 4 metabolism and activation of parts of the MAP kinase pathways. Nevertheless, cooling and warming of DDT 1 MF-2 cells did not only infl uence ERK1/2 and p38 but also PP 2 -InsP 4 levels. Compared to osmotic stress, the PP 2 -InsP 4 increase arising from thermal stress was approximately 3 -4 times lower. Combination of both stimuli had an additive effect on the accumulation of PP 2 -InsP 4 . Choi et al. (2005) also utilized Saccharomyces cerevisiae as a model system to study the molecular mechanisms of PP 2 -InsP 4 generation. With mutant yeast strains where Kcs1 was deleted they had a control where the synthesis of the PP 2 -InsP 4 was blocked. Indeed, they observed slower growth of the mutant strains as an effect of increased salt (0.8 m NaCl), heat shock (25 ° C -37 ° C) and osmotic stress (1 m sorbitol) in comparison to WT strains exposed to the same conditions. But again they could not work out a solid correlation between the changes of growth and PP 2 -InsP 4 level changes. With HPLC analyses they ruled out that yeast might synthesize DPIPs structurally different from the mammalian ones in response to stresses. In conclusion, these data show that raised levels of PP 2 -InsP 4 upon special stress conditions appear to be specifi c to mammals, because neither stimulus affected the PP 2 -InsP 4 levels in yeast. The involvement of MAP kinase pathways specifi c for stress signaling was fi nally disproved (Choi et al. , 2008 ) . Presently we thus only know that the environmental stresses induced by sorbitol and heat stimulate the levels of PP 2 -InsP 4 in mammalian cells.
Infl uence of energy charge on diphosphoinositol phosphates and vice versa
It is important for cells to maintain a suffi cient level of high energy phosphate, in particular of ATP. ATP is rapidly turned over and its level infl uences many metabolic fl uxes, ATPases, and also certain substrate kinases. If the ATP consuming processes generate a high level of ADP, e.g., in electrically excitable and muscle cells, the aerobically built-up cytosolic creatine phosphate energy store and the adenylate kinase reaction are able to recover certain amounts of ATP fairly quickly. The latter enzyme converts two molecules of ADP to one ATP and one AMP and is only mass action driven. As a result of a long-lasting energetic stress, the cellular concentration of AMP will increase, whereas [ADP] and [ATP] decrease (for a review see Dzeja and Terzic , 2009 decreases, and in particular AMP becomes a signal acting on multiple energy restoring metabolic systems via the activation of AMPK (for a review see Steinberg and Kemp , 2009 ; Carling et al. , 2011 ) .
In DPIP generating kinases the γ -phosphate of ATP is also transferred to the InsP substrate. All known phosphoester generating InsP kinases have low K m values for ATP below 100 μ m in their active states similar to most protein kinases (Table 4) . However, among the DPIP generating kinases, the IP6K family of kinases (determined for IP6K1 and 2) are characterized by a signifi cantly higher K m value for ATP (Table 4) at approximately 1 m m range. Thus, the synthesis of the 5PP-InsP 5 and PP-InsP 4 from InsP 6 or Ins(1,3,4,5,6)P 5 , respectively, are critically dependent on the cellular level of ATP. By contrast, the dephosphorylation of DPIPs to the corresponding inositol phosphates are not known to depend on AMP or the energy charge (see above), implying that a loss of ATP mainly should lead to a decrease of the above-mentioned DPIPs by reduced biosynthesis. To understand the metabolism of the inositol phosphates, the catabolic pathways were inhibited by treating mammalian cells with 5 -10 m m NaF for at least 1 h (Menniti et al. , 1993 ; Albert et al. , 1997 ) , and in fact the degradation of InsP x and in particular of PP-InsP x was largely abolished (see data above). We now know that the accumulation of PP-InsP 5 and PP 2-InsP 4 is the result of an almost full inhibition of DIPP due to its fl uoride sensitivity (see above). studied the infl uence of fl uoride on the inositol phosphate turnover in more detail. On treatment of DDT 1 MF-2 cells with 10 m m fl uoride, a decrease of PP 2 -InsP 4 to approximately 70 % of the control level occurred for 20 -30 min, although the phosphatases should be fully inhibited by fl uoride . After the initial decrease, the PP 2 -InsP 4 level surprisingly began to recover. After treatment of different cell lines with 10 m m fl uoride for 2 h the mass levels of both PP-InsP 5 and PP 2 -InsP 4 were signifi cantly increased throughout (Albert et al. , 1997 ; Lin et al. , 2009 ). found that a depletion of cellular ATP to approximately 70 % of the resting level was responsible for the transient decrease of PP 2 -InsP 4 . Because ATP remained decreased, the re-increase of PP 2 -InsP 4 was rather due to long-term DIPP inhibition by fl uoride as also evidenced by the mass analyses (above). The reason for this complex phenomenon comes from a second effect of fl uoride to deplete ATP and thereby to increase levels of ADP and AMP (Clarke and Weigel , 1985 ) . These experiments with fl uoride showed the high complexity of the regulation of the whole inositol phosphate metabolome and provide additional strong evidence with regard to the infl uence of the cellular energy potential on the levels of InsP 6 and the DPIPs. The Shears group also tried to work out whether fl uoride might infl uence the levels of PP-InsP 5 and PP 2 -InsP 4 by its third known cellular effect, namely to stimulate G-proteinmediated signaling events . For this purpose, they further stimulated these G-protein-dependent fl uoride effects with agonists and drugs. They found that a strong increase in cyclic nucleotides led to a decline in PP 2 -InsP 4 levels. By using specifi c inhibitors of protein kinase A or G (PKA or PKG) to disrupt the downstream signaling of cyclic nucleotides while treating cells with various stimulants of these second messengers, they found that the regulation of PP 2 -InsP 4 by cAMP and cGMP apparently occurs in a PKAor PKG-independent manner. Because neither an involvement of cyclic nucleotide gated CNG channels nor a participation of the cAMP regulated GEFs named EPACs (de Rooij et al. , 2000 ) are likely in this process other unknown mechanisms might be active. To specifi cally study the effect of AMP in more detail, Choi et al. (2008) simulated an increase of AMP in DDT 1 MF-2 cells without largely altering the cellular levels of ATP. In one protocol, the cell permeable purine nucleoside analog AICAR (aminoimidazol-carboxamide-ribonucleoside) was added to the cells which is phosphorylated to the monophosphate ZMP inside the cell (Mullane , 1993 ) . This mimics an increase of cellular AMP and stimulates AMPK (Sullivan et al. , 1994 ) . In addition, when the ATP synthase inhibitor oligomycin was applied (for a review see Weber , 2006 ) , the ATP level was not affected either, but the cellular AMP increased. Both treatments resulted in decreased PP 2 -InsP 4 levels. Furthermore, the drugs employed were shown not to inhibit PPIP5K. These treatments affect PP-InsP 5 levels and furthermore also activate AMPK. This raised the possibility that the link between energy status and regulation of PP 2 -InsP 4 levels could be AMPK, which itself is a fi ne-tuned energy sensor responsible for the switch from energy consuming to energy providing pathways (Hardie , 2011 ) . To rule out this possibility, they reduced total AMPK levels by RNAi and found an identical drop in AICAR stimulated PP 2 -InsP 4 levels in the knockdown and in control cells. These results proved that an increase of the AMP to ATP ratio unequivocally infl uences the levels of PP 2 -InsP 4 through an AMPK-independent pathway (Choi et al. , 2008 ) .
The Saiardi laboratory developed experiments to observe the reverse infl uence of DPIPs on the energy level. With mutant yeasts as model systems they investigated the levels of ATP and the energy potential in response to changing PP-InsP 5 /InsP 6 levels . They used yeast strains with genetic depletion of several kinases responsible for the metabolism of inositol phosphates as well as for pyrophosphorylation of inositol phosphates. These mutated strains were assayed for their InsP levels, which to no surprise were specifi cally reduced with regard to the respective deleted kinase. Strikingly, dramatically altered levels of ATP vs. ADP and AMP of the deletion strains lacking PP-InsP 5 (and PP 2 -InsP 4 ) compared to those of WT yeast were observed. To sum up their results, the ATP concentration is inversely related to the concentration of PP-InsP 5 . In strains where the levels of PP-InsP 5 are reduced, the observed ATP concentration is elevated. This implies a reduction of AMP or ADP leading to a raised AEC and in fact they could also prove that. To underline their observations, overexpression of IP6K in WT yeast was performed which resulted in an expected rise of PP-InsP 5 levels (which should be 5PP-InsP 5 ) but also in reduced ATP concentrations. The relationship between ATP and 5PP-InsP 5 was similar in MEF (mouse embryonic fi broblast) cells that homozygously lack IP6K1 in comparison to WT MEF.
Based on this report and that of Choi et al. (2008) , one may argue inconsistent interrelations between DPIPs and energy metabolism in yeast and mammalian tumor cells. However, there is no need for an identical type of dependence of the cellular response to the applied perturbation if the perturbation and response are causally interchanged. In the experiments by Choi et al. (2008) , the AMP/ATP ratio and thus the AEC were short-term perturbed and the effects on PP-InsP 5 and PP 2 -InsP 4 were analyzed, i.e., cellular conditions altering the production of DPIP signals were searched. These data revealed a positive type of correlation in hamster and human cells between the perturbed AEC and the levels of PP-InsP 5 and PP 2 -InsP 4 as a cellular response. When the AEC decreases, also the radioactive PP 2 -InsP 4 level decreases. By contrast, in the studies by Szijgyarto et al. (2011) , the levels of PP-InsP 5 were long-term perturbed anticipating it is a modulator of any cell response and the AEC and the underlying tunable ATP regenerating systems were found as cellular response systems. Now DPIPs and AEC are inversely correlated. Is this just due to the differences between a mainly monocellular or a multicellular organism and to differences between a shortterm perturbation in the latter or permanent notation in the former or is there a common logic explaining all interrelations in all organisms investigated ? We believe the latter.
To better explain the underlying logic of these interrelations, just consider the effect of blood glucose on insulin as a signal and vice versa (see Figure 4 with explanatory schemes). When blood glucose falls, the plasma insulin level falls, when it increases, the latter also increases, i.e., in that causal direction both parameters are positively correlated. However, when the plasma insulin is artifi cially increased, the blood glucose is falling, when insulin is decreased, blood glucose is increasing. Insulin is a negatively regulating extracellular ' actor ' of an endocrine ' glucostat ' system keeping blood glucose increases below a threshold and driving it back to a constant level.
Such a regulator system is well known from engineering. Its purpose is to entrain a parameter, blood glucose in our case, within a defi ned magnitude range and it consists of an ' actor ' or several ' actors ' which are able to set back deviations of the adjustable parameter (blood glucose) towards the present range. The defi nition of ' actors ' in a biological system is unusual but they are just signal transduction systems which measure -i.e., generate a signal which is somehow proportional to upper or lower the deviations of -the adjustable parameter and employ effector reactions which are suitable to readjust the parameter to within the allowed range. The ' actors ' entrain the adjustable parameters. We will keep to the designation ' actor ' when describing upper or lower parts of the entrainment signaling system. Biological regulator systems often employ different sets of ' actors ' for the upper and lower entrainment, respectively.
Transferring this model to the control system highlighted by the above-described experiments, it is becoming somewhat clear that DPIPs might be ' actors ' similar to insulin with the difference of possibly regulating only intracellular homeostasis internally, whereas insulin acts from outside on most cells being responsible for the organism glucose homeostasis. Cellular formation of PP-InsP 5 and PP 2 -InsP 4 in fact appears to be ' fuel driven ' and thus perfectly coupled to the parameter to be regulated, AEC. Additional requirements for such an ' actor ' of a regulator system are also perfectly met. Firstly, their formation must not strongly depend on changes of the substrate pool, InsP 6 and InsP 5 , respectively, a condition which appears to be met by the high concentrations of both precursors and the low K m values both of Kcs1/IP6K and Vip1/PPIP5K for InsP 6 (Table 4) . Secondly, specifi c activities and cellular amounts of these enzymes are low leading to slow cellular rates of product formation, i.e., an integration type of behavior. Thirdly, the rapid dephosphorylation by DIPPs requires a permanent resynthesis and allows a relatively rapid decrease when the driving force for synthesis, AEC, falls, i.e., it gives the regulator a proportional type of behavior. Thus, the so-called PI regulator is set up largely ignoring high frequency instabilities of the AEC but being well correlated with average AEC changes over time. We can name this system in analogy to the ' glucostat ' system an ' adenylate energostat ' or just ' energostat ' (Figure 4) . Questioning whether there is a necessity to prevent an overshooting cellular AEC the answer is defi nitely yes. Excess ATP (i) allosterically inhibits kinases, e.g., phosphofructokinase 1; (ii) critically reduces cellular P i thus limiting oxidative and substrate chain phosphorylation; (iii) complexes free Mg 2 + , which is essential for numerous non-MgATP binding enzymes; (iv) alkalizes cells by binding excess protons; and (iv) may perturb RNA synthesis due to an imbalance of ribonucleotide supply to RNA-polymerases. In fact, the cellular resting ATP is always kept below a threshold which in different cell types only varies between approximately 4 m m in non-excitable cells and approximately 8 m m in skeletal muscle (Gupta and Yushok , 1980 ; Kushmerick et al. , 1992 ) . Importantly, the ' glucostat ' system is a twosided entrainment system having also ' actors ' limiting crucial decreases in the glucose level: adrenaline is activating reactions saving glucose demand by peripheral cells; glucagon is stimulating glucose release by the liver and cortisol is managing amino acid supply for liver gluconeogenesis thereby supporting glucagon. In Figure 4 , only two of these ' actors ' are depicted for simplicity. Analogously, we do have ' actors ' in the ' energostat ' restraining too excessive falls in the AEC. The most important system is evidently the AMPK system already mentioned above as an AMP sensor-effector system with a large number of cellular targets addressed in a way restoring the AEC. However, also key enzymes of energy metabolism are allosterically regulated by AMP or ADP and thus participating in the downward restraining regulation of the ' energostat ' . Fructose 1,6 bisphosphatase (FBP1) and glycogen synthase are inhibited by AMP, phosphorylase b and 1-phosphofructokinase are activated by AMP, and pyruvate dehydrogenase is activated (via PDH kinase) by ADP. There also must be a direct target for AMP reducing the levels of DPIPs due to the fi ndings from the Shears laboratory (above) but it is not known yet.
A rather fascinating link between the organismic ' glucostat ' ' actor ' insulin and the cellular ' adenylate energostat ' ' actors ' 5PP-InsP 5 and PP 2 -InsP 4 as an indication of the true physiological cooperation between both homeostasis systems has been uncovered by Illies et al. (2007) and Bhandari et al. (2008) . Illies et al. (2007) overexpressed IP6K1 in pancreatic β -cells where IP6K1 is the dominant IP6K isoform. They found that the product 5PP-InsP 5 in a dose-dependent manner increases stimulated exocytosis of insulin. 5PP-InsP 5 biosynthesis is increased, i.e., is under positive control of the AEC. The necessary production of inositol phosphate precursors by phospholipase C is controlled by adrenergic receptors activating phospholipase C and also stimulating insulin secretion. The second driving force for insulin secretion is the intensively studied ' fuel-driven Ca 2 + -stimulated exocytosis ' . The β -cell is selectively taking up mainly glucose as metabolic ' fuels ' via GLUT2 leading to a high ATP/ADP ratio when blood glucose is high, which leads to inhibition of an ADPinhibited potassium channel. The resulting depolarization opens voltage-dependent Ca + 2 channels, whereby the resulting Ca 2 + infl ux activates Ca 2 + -dependent insulin secretion (Prentki and Matschinsky , 1987 ) . Thus, both the generation of 5PP-InsP 5 as an insulin secretagogue and the potassium channel inhibition leading to Ca 2 + driven insulin secretion Figure 4 Model of a cellular regulation system termed cellular ' energostat ' and linked to the organismic endocrine ' glucostat ' regulation system. In the cellular ' energostat ' regulation system the deviation of the adenylate energy charge (AEC) or the ATP/AMP ratio is the regulated cellular parameter which is hysteretically entrained between an upper threshold by the ' actors ' 5PP-InsP 5 and PP 2 -InsP 4 , and a lower threshold by the ' actors ' AMP and AMP-kinase. Both sets of ' actors ' are components of upper and lower regulator elements apparently showing the characteristics of PI regulators, regulating the delta of the measured parameter back proportional to the signal and complemented with an integrator element to smooth rapid parameter changes, i.e., oscillation ATP and AMP changes. By the upper and lower regulatory elements of the ' adenylate energostat ' system the cellular AEC is kept between a maximal and a minimal level which is tolerable by cells. The entrainment system is coupled to the organismic endocrine ' glucostat ' regulation system where the deviation of the blood glucose is hysteretically regulated back below an upper limit by insulin secretion and up above a lower threshold by glucagon and adrenaline secretion. Other ' actor ' elements of the lower regulator for delta glucose are omitted for simplicity. The link between the cellular energostat regulators and the glucostat is realized on the β cell level. There, both the positive magnitude of PP-5PP-InsP 5 /PP 2 -InsP 4 and the AEC are intracellular drivers of insulin secretion. Blunted arrows indicate negative feedback actions, pointed arrows positive actions. Adrenalin, in addition to positive actions setting back a glucose decrease, has also a positive effect on β -cells which are likely to provide the precursor of DPIPs, InsP 3 , with PLC activation. An unknown analogous system in the cellular ' energostat ' must exist to provide precursors of DPIPs. Owing to experimental evidence there appears to be a direct inhibitory action of AMP on DPIP formation. DPIPs are also P i uptake stimulators independent of the cellular free P i (see text). The other effects on targets of the upper ' actor ' are indicated by arrows.
are similarly controlled by the AEC. When blood glucose is high, insulin secretion is increased which sets blood glucose back to lower values. When blood glucose is low, the β -cell AEC is also low, limiting further secretion of insulin via both mechanisms, allowing a re-increase of blood glucose via the action of, e.g., glucagon and adrenalin as glucose increasing hormones. Bhandari et al. (2008) generated IP6K1 knockout mice and found as a perfect complementation of the Illies data (Illies et al. , 2007 ) a signifi cant decrease in plasma insulin to 65 -70 % of WT levels. In fact, the lack of 5PP-InsP 5 of the β -cells appears to be fooling the cells in making them interpret the low 5PP-InsP 5 as a result of a low AEC, due to a low glucose uptake due to low blood glucose. This is proof that in fact 5PP-InsP 5 is a strong dominant ' actor ' of the mammalian ' glucostat ' . These mice also have lower body weight, lower body fat, and show insulin hypersensitivity, i.e., respond with a stronger decrease in blood glucose to a certain dose of insulin. The authors of the study could not explain the latter mechanistically. Taking into account that the IP6K1 knockout acts on all or most body cells, the cellular ' adenylate energostat ' in many organs and tissues such as muscle and fat cells will be fooled in a way, signaling cells erroneously a low AEC. Therefore, the cells will be driven to take up and metabolize more glucose than normal at certain plasma insulin, i.e., show insulin hypersensitivity and burn more fat in fat cells to cope with the virtual lowering of their AEC. All the observed phenomena again indicate that 5PP-InsP 5 is a dominant ' actor ' of the ' adenylate energostat ' overlaying other metabolic regulatory systems directly responding to andenylate metabolites.
One of the likely multiple mechanisms how the product of IP6K is exerting cellular effects on the energy potential of mammalian cells is highlighted by the Chakraborty et al. data in MEF cells and by Prasad et al. in neutrophils (Chakraborty et al. , 2010 ; Prasad et al. , 2011 ) . These will be discussed in the section Competition of 4, 5) 
Recently, Szijgyarto et al. (2011) published more intriguing details of their 2011 yeast studies and the data perfectly support the novel model of how DPIPs might regulate the AEC in yeast (Figure 4) . Because PP-InsP 5 depletion triggered an increase in ATP, they studied the mitochondrial state in these conditions. To their surprise, they found respiratory inactive mitochondria in yeast that lack both Kcs1 and Vip1, or Kcs1 alone. Detailed respiratory investigations as well as microscopy after differential mitochondrial staining underlined a similar deterioration of mitochondria not only in yeast but also in the dominant IP6K knockout MEF cells. At fi rst sight it seems unlikely that cells possessing mitochondria and undergoing less respiration have higher amounts of ATP than WT cells. However, applying the ' adenylate energostat ' model it is logical that cells artifi cially having a low of PP-InsP 5 ' actor ' concentration and thus being fooled to have a low AEC should respond with an AEC increase. Because the redox state, glucose uptake, and ethanol production were elevated in the mutant strains with PP-InsP 5 depletion, key enzymes for increased glycolysis and anaerobic fermentation were analyzed and verifi ed to be more strongly expressed. Yeast as a facultative anaerobic organism is known to effectively switch from oxidative phosphorylation to anaerobic fermentation when changes of environmental sources make this necessary (for a review see Kwast et al. , 1998 ; Santangelo , 2006 ) . Obviously, the loss of PP-InsP 5 in the mutant strains was causal for the expression of the glycolytic and fermentative enzymes and also for mitochondrial degradation.
A direct inhibitory infl uence of the inositol pyrophosphate on yeast transcription regulators Gcr1 and Gcr2 (Santangelo , 2006 ) essential for the expression of glycolytic key enzymes and some ribosomal genes was further investigated. In Gcr1, a transfer of the β -phosphate of PP-InsP 5 to prephosphorylated pGcr1 could be demonstrated, which could diminish protein-protein interaction with other factors of the transcription machinery thereby inhibiting transcription. When this modifi cation of Gcr1 would occur in stoichiometric amount, the presence of PP-InsP 5 synthesized by Kcs1/IP6K might inhibit glycolytic fermentation, and its absence dramatically stimulate the latter. Details of the observed phosphate transfer will be discussed in the subsequent section. How mitochondria are deteriorated by the absence of PP-InsP 5 remains elusive at present.
Because in exponentially growing yeast there is clear evidence that P i starvation signifi cantly reduces both the ATP and the polyphosphate content (Boer et al. , 2010 ; Lonetti et al. , 2011 ) , it might be useful when the cellular ' energostat ' would be linked to P i homeostasis. Undoubtedly, deprivation of P i during exponential growth also lowers PP-InsP 5 (Lonetti et al. , 2011 ) , which is in full agreement with our energostat model. The reduction of PP-InsP 5 drives the AEC towards higher levels in spite of P i deprivation. A possible mechanism might be a degradation of polyphosphate to provide growing cells still with suffi cient P i to replenish some ATP. Intriguingly, levels of PP-InsP 5 do not fall to zero (Lonetti et al. , 2011 ) . This possibly is due to the necessity to still synthesize 1PP-InsP 5 and (some) 1,5PP 2 -InsP 4 as P i uptake regulators (see section above) .
Pyrophosphorylation of prephosphorylated eukaryotic proteins by diphosphoinositol phosphates
Phosphorylation of proteins is the most abundant mechanism of post-translational modifi cation (PTM). Protein kinases that are responsible for these post-translational processes belong to one of the largest family of genes in eukaryotes. The human genome contains 478 genes for typical protein kinases and 40 genes for atypical protein ones, making up approximately 2 % of the human genes (Manning et al. , 2002a,b ) . Only a fraction of these protein kinases as well as their substrates or binding motifs are further studied to date (Ubersax and Ferrell , 2007 ) . The enormous quantity of genes discloses no doubt that protein phosphorylation is an event that controls and regulates most cellular processes and nearly every signal transduction (Manning et al. , 2002a,b ; Ubersax and Ferrell , 2007 ) . Numerous further PTMs range from the well-known protein glycosylation via SUMOylations (for a review see Lomeli and Vazquez , 2011 ) to the less familiar and apparently unique lysine hypusination of the eukaryotic translation initiation factor 5A (eIF5A) (Park , 2006 ) .
A novel possibility of phosphorylation enabled by DPIPs is gaining increasing experimental confi rmation. In addition to the catalytic activity of converting inositol phosphates, the Snyder laboratory showed that purifi ed IP6K is able to act as an ATP synthase in vitro in transferring the β -phosphate of 5PP-InsP 5 back to ADP to create ATP (Voglmaier et al. , 1996 ) . A biochemical reaction fairly analogous to the above one is the adenylate kinase reaction, where the β -phosphate from ADP is transferred to a second ADP. With the possibility of PP-InsP 5 acting as a phosphate donor they hypothesized a phosphorylation of proteins mediated by the high energy phosphoanhydride bond of PP-InsP 5 . Then 8 years later, Saiardi and Bhandari furnished evidence for this hypothesis (Saiardi et al. , 2004 ) . They radiolabeled the β -phosphate of the diphosphate moiety of 5PP-InsP 5 with 32 P and in fact found a radioactivity transfer to cellular proteins in the eukaryotic cell but never in bacterial extracts. The reaction was increased by phosphatase inhibitors such as fl uoride, okadaic acid, and tautomycin but was unaffected by orthovanadate and β -glycerol and was essentially dependent on either Mg 2 + or Ca 2 +
. Three noticeable phosphorylated proteins in yeast extract with a size of 60, 63, and 98 kDa, respectively were identifi ed as the nuclear ribosomal assembly protein Nsr1 (60 kDa), the nuclear ribosomal chaperone Srp40 (63 kDa), and the cytosolic protein Ygr130c, whose function is still unknown. To further verify their fi ndings, all three proteins were overexpressed in yeast and extensively examined. Intriguingly, protein denaturation controls revealed that the phosphate transfer occurs independently from any enzyme activity but not by chance. Only serine residues were modifi ed when these were fl anked by several acidic amino acids and eventually lysines. Proteins containing such a motif are not restricted to yeast proteins but can also be found in mammals. As an example they proved a non-enzymatic phosphorylation of a similar acidic amino acid segment found in mammalian TCOF1 (Treacher Collins-Franceschetti syndrome 1) and Nopp140, the mammalian ortholog of SRP40. Also, 1PP-InsP 5 as well as 1,5PP 2 -InsP 4 were substrates for this reaction (Bhandari et al. , 2007 ) , but the degree and pattern of phosphorylation was unchanged. While it remains intriguing that a PTM should occur nonenzymatic, a protein kinase, namely CKII still is involved. CKII is a ubiquitous serine/threonine protein kinase involved in several cellular processes, but to date the regulation of CKII is not really understood (for a review see Montenarh , 2010 ) . Notably, CKII alone (Solyakov et al. , 2004 ) and CKII in a complex with Nopp140 (a nucleolar protein) are upregulated by InsP 6 binding (Kim et al. , 2006 ; Lee et al. , 2008a ) . Nevertheless, the serine in such an acidic stretch needs to be prephosphorylated or ' primed ' by CKII and ATP (Bhandari et al. , 2007 ) . This phosphoserine is now the target of the nonenzymatic pyrophosphorylation ( Figure 5 ). With the help of synthetic peptides containing the above signature they proved that pyrophosphate moiety formed at the primed serine and excluded a triggered phosphorylation of a second neighboring serine. Phosphorylation-dephosphorylation events accomplished by protein kinases and phosphatases are in most cases occurring as rapid responses to external or internal stimuli and have a half-time in the minute range. Bhandari et al. (2007) showed that a peptide diphosphate is more acid labile than a peptide serine, threonine, or tyrosine phosphate. However, the diphospho-serine is phosphatase-and even pyrophosphataseresistant. Therefore, pyrophosphorylation might represent a more stable or long-lasting modifi cation of a target protein.
How the modifi cation will be removed again remains unclear. Based on the identifi cation of the clathrin-associated protein complex AP-3 β ( a daptor p rotein complex 3 subunit β ) and the yeast transcription factor Gcr2 as two further protein targets of this type of theoretical PTM (Azevedo et al. , 2009 ; Szijgyarto et al. , 2011 ) in the Saiardi group revealed or postulated, respectively, a diminished protein-protein interaction of AP-3 or Gcr1 with their respective binding proteins Kif3A or Gcr2 upon pyrophosphorylation. The proposed inhibitory principle is a steric blockage based on disruption of an essential protein-protein interaction.
Nevertheless, some controversy with regard to this PTM exists (York and Hunter , 2004 ; Shears , 2010 ; Irvine and Denton , 2011 ) . The greatest problem in addition to confi rmation from other laboratories is the lack of proof of a reasonable stoichiometry of the modifi cation by a real determination of modifi cation stoichiometry, e.g., of pmols of [ 32 P]phosphate transferred from β [ 32 P]-PP-InsP 5 to a pmol of protein in interest, and no such experimental derivation is available from the papers published to date. Admittedly, e.g., for transient SUMOylations where SUMO is a type of ' catalyst ' , a rather low stoichiometry of modifi cation of a protein is suffi cient (Lomeli and Vazquez , 2011 ) . However, for the proposed action model of a steric hindrance of protein-protein interaction by the pyrophosphorylation we recognize a problem with low modifi cation stoichiometry, because the majority of unmodifi ed target protein still could undergo protein-protein interaction.
Competition of 5PP-InsP 5 and PtdIns(3,4,5)P 3 for PH domains PH domains (pleckstrin homology domains) are involved in protein-protein and in a smaller fraction of these domains in protein-phospholipid interactions. Database searches for PH domain containing proteins in the human proteome indicate 561 of these domains (Letunic et al. , 2012 ) . They participate in a broad variety of cellular functions. The physiological function of phospholipid-interacting PH domains is the recruitment of PH domain-containing proteins towards a membrane upon a signaling event that result in phosphorylation of phosphoinositides (PIPs). PIPs are inositol phosphate head groups containing phospholipids. Similar to the soluble InsPs, the head group of phosphatidyl inositol can be phosphorylated at different positions, some of which are recognized by the PH domains with high affi nity. Binding partners of these PH domains are not only the membrane bound PIPs (mainly PIP 2 and/or PIP 3 ) but also the soluble inositol phosphate head groups (Lemmon and Ferguson , 2000 ) . Furthermore, soluble InsP 5 isomers and InsP 6 , not found as head groups of phospholipids yet, are also capable of binding PH domain-containing proteins and are therefore able to inhibit the recruitment of the respective proteins to PIPs (Komander et al. , 2004 ; Piccolo et al. , 2004 ; Jackson et al. , 2007 Jackson et al. , , 2011 . The fi rst evidence of an interaction between DPIPs and PH domains occurred in the Snyder laboratory. They identifi ed a binding of Dictyostelium PP-InsP 5 , which is a mixture mainly of 6PP-InsP 5 and 5PP-InsP 5 (Albert et al. , 1997 ) to different PH domains in vitro and in vivo (Luo et al. , 2003 Figure 5 Pyrophosphorylation of a primed serine within an acidic peptide segment. By peptide synthesis, an acidic pyrophosphorylation cluster is built, where fl anking acidic amino acids (represented by negative charges) are surrounding at least one serine (represented by the hydroxyl). Lysine residues (represented by positive charge) are near the serines. (A) One serine of the acidic segment is pre-phosphorylated (primed) by CKII. (B) Owing to the specifi c distribution of amino acids, the appropriate inositol pyrophosphate (InsP 7 in this case) is probably coordinated by Me 2 + chelation complexes and ion pairing with lysines and transfers its β -phosphate in an enzyme-independent manner to the primed serine to form a pyrophosphorylated peptide.
caused an augmented chemotactic sensitivity due to a relief of the inhibitory effect of PP-InsP 5 . They identifi ed PH domain-containing proteins such as Crac (cytosolic regulator of adenylyl cyclase) as targets. In addition to Crac they explored three mammalian PH domain-containing proteins (Akt, PIKE, and TIAM) and verifi ed a similar binding of PP-InsP 5 as for Crac. They outlined a proposed model where PP-InsP 5 competes with the binding and therefore inhibits the ongoing event by disruption or downregulation of the signaling pathways of PI3K (phospho i nositide 3-kinase) (Luo et al. , 2003 ) .
The PI3K pathway with its phosphoinositide messenger PIP 3 is involved in numerous cellular functions (Manning and Cantley , 2007 ) and has been further studied with regard to the infl uence of 5PP-InsP 5 (Chakraborty et al. , 2010 ; Prasad et al. , 2011 ) . One function that has been examined in detail is the response to insulin. Insulin stimulates the serine protein kinase Akt/PKB downstream of PI3K and PIP 3 which leads to protein translation, glucose uptake and glycogen synthesis. The energetic connection between PP-InsP 5 and insulin secretion in β cells was already discussed earlier. It therefore was interesting if and how cellular PP-InsP 5 might also interfere with insulin-activated mechanisms in peripheral target cells. Chakraborty et al. (2010) confi rmed the interaction of PP-InsP 5 with PH domain-containing proteins thereby disrupting the ongoing signaling event. In more detail, the authors have elucidated the inhibitory binding of PP-InsP 5 to the PH domain of Akt/PKB. Incubating Akt/ PKB fi rst with increasing PP-InsP 5 and then adding its normal activator PIP 3 revealed an IC 50 value for PP-InsP 5 of 20 n m which is slightly lower to the K d value of 35 n m for PIP 3 (Currie et al. , 1999 ) . Akt/PKB-mediated phosphorylation is among others increasing cellular glucose uptake, cellular glycogen via GSK3 β (glycogen synthase k inase 3 β ) inhibition and protein translation via mTOR. PP-InsP 5 binding to Akt/PKB prevented it partially from phosphorylation and activation by PDK1 at T308 which led to reduced mTOR activation and elevated GSK3 β activity and therefore to reduced protein translation and decreased glycogen biosynthesis. Considering the action of 5PP-InsP 5 in the ' adenylate energostat ' model (Figure 4) , its observed cellular action again fi ts to the expected action from the model: glucose uptake is reduced and thus the energy potential is lowered when cells experience high PP-InsP 5 .
These experiments are in fact highlighting the fi rst cellular target system which appears to be addressed by high 5PP-InsP 5 signaling and high AEC in order to bring the energy balance back to normal. Loss of PP-InsP 5 in the IP6K1 knockout mice (see above) leads to enhanced glucose uptake after insulin, enhanced fat burning resulting in body weight loss under high fat feed. Without any doubt this shows that the cells are fooled by their defect. They are in a state as if the ' actors ' AMP and AMPK which are active at a low AEC, were switched on ( Figure  4) . However, in reality just the balance between energy potential increasing and decreasing forces are in disequilibrium. The ' glucostat ' regulation ( Figure 4 ) recognizes a situation, which is perfectly analogous to this IP6K1 knockout in mice: that is, the absolute lack of insulin in juvenile diabetes. These juveniles have an incredibly similar phenotype than the IP6K1 knockout mice. Again, the corresponding upper regulator part is ' actor ' -defi cient (i.e., insulin-defi cient). Consequently, even at normal glucagon, the organism responds as if glucagon were in strong excess. However, in reality just the balance between hypoglycemic and hyperglycemic forces is in disequilibrium. This raises the question whether hitherto incompletely understood peripheral insulin resistances, in most cases occurring as a consequence of high fatty acid intake, might in fact be mediated by high PP-InsP 5 made as a consequence of a long-term increase in AEC.
The latest study that should be mentioned here addresses the infl uence of 5PP-InsP 5 on Akt/PKB in neutrophils (Prasad et al. , 2011 ) . The authors found the same inhibitory effect of IP6K1-derived 5PP-InsP 5 on Akt/PKB in the PI3K pathway and furthermore excluded an infl uence of non-enzymatic protein pyrophosphorylation. By examining IP6K1-depleted neutrophils or employing the purine analogous IP6K inhibitor TNP (N 2 (m-(trifl uoromethyl) benzyl) N 6 -(p-nitrobenzyl) purine) (Padmanabhan et al. , 2009 ) , they found an increased phagocytic and bactericidal ability and an amplifi ed NADPH oxidase based reactive oxygen burst. They concluded that IP6K1-derived 5PP-InsP 5 is one of the key regulators (an inhibitor) of the phagocytic and bactericidal pathway. Checking against the ' adenylate energostat ' model we again have a compatible situation: reduction of 5PP-InsP 5 makes the cells believe there is a reduced AEC, induces an increased glucose uptake, and an increased AEC, which in turn facilitates ATP and NADPH consuming defense reactions. This understanding of the action of reduced PP-InsP 5 inducing an increase of the cellular AEC could make inhibitors of IP6K and PPIP5K attractive drug candidates suitable to increase cellular energetics, e.g., in cases of severe adipositas, maturity onset diabetes, or brain and aging related diseases.
Modulation of vesicle traffi cking by diphosphoinositol phosphates
That inositol phosphates participate in the clathrin assembly machinery and therefore are involved in regulation of vesicle traffi cking was elucidated in the 1990s. The fi rst identifi ed interacting assembly protein of clathrin coated vesicles was AP-2 in vitro (Voglmaier et al. , 1992 ) . Binding of InsP 6 to AP-2 inhibits the formation of the clathrin-coated vesicles. Further inositol phosphates participating in this negative regulation Ins(1,3,4,5)P 4 and PP-InsP 5 were identifi ed by Fleischer et al. (1994) . In addition to their direct binding, Fleischer et al. (1994) showed that coatomers responsible for the intercisternal golgi vesicle transport when integrating into the lipid bilayer are able to build a K + -selective channel that itself can be fully inhibited by Ins(1,3,4,5)P 4 at 10 μ m , InsP 6 at 1.0 μ m and PP-InsP 5 as the most potent one at 0.27 μ m (Fleischer et al. , 1994 ) . The neuronal clathrin binding protein AP180 (also named AP-3) was also shown to interact with both InsP 6 and PP-InsP 5 where the DPIP again was the most potent inhibitor of the clathrin assembly (Norris et al. , 1995 ; Ye et al. , 1995 ) .
Because most of these studies were performed in unphysiologically low salt, the only remaining active ligand might in fact be the DPIP.
Future research
After the 20-year period of discovering the structures and the enzymes responsible for this unique group of high energy inositol phosphates we need much more knowledge about their biological targets, regardless whether being addressed by just physically binding these compounds or taking over a covalent phosphate. Does the research on targets of their precursor, InsP 6 , give hints how this could be enhanced ? InsP 6 contains approximately ten negative charges in its metal-free form at pH 7.0, enabling it to chelate not only di-or multivalent ions (Bohn et al. , 2008 ) but also to bind specifi cally to proteins bringing them into specifi c, active conformations or multimeric complexes. The growing body of papers demonstrating InsP 6 protein binding such as Gle1 (Alcazar -Roman et al., 2006 ; Weirich et al. , 2006 ) , Dbp5 (Montpetit et al. , 2011 ) , ADAR2 (Macbeth et al. , 2005 ) , and Ku proteins (Ma and Lieber 2002 ) begins to reveal such direct protein binding functions of inositol phosphates.
Inside cells (pH 7.0 -7.1), where resting Ca 2 + is below micromolar and cellular Mg 2 + is the prevailing free cation varying between 0.5 and 1.5 m m free concentration, according to the calculations of Kremer and coworkers (Veiga et al. , 2006 ) , a solubility window of the dominant hydrated (Mg) 5 H 2 InsP 6 complex of up to 49 μ m should exist. In fact, many cellular total InsP 6 measurements revealed values below 50 μ m , but in other cells also higher total concentrations up to 100 μ m were found (Table 2 ), in particular when correcting for a cytosolic plus nuclear water content of only 70 % of the wet weight of cells (see references in Veiga et al. , 2006 3 H] myo-inositol demonstrated that a fraction of InsP 6 comprising > 50 % of the total prelabeled amount is apparently soluble and rapidly released. A smaller fraction effusing slower is a clear indication of limited diffusion or scavenging, respectively, of part of the prelabeled InsP 6 (Stuart et al. , 1994 ) . Both phenomena, oversaturation and immobility, indicate not all of the total cellular InsP 6 to be freely soluble. It is rather likely that a fraction of the InsP 6 is bound to proteins. Crystallography of eukaryotic expressed proteins in fact provides an increasing number of proteins with tightly bound InsP 6 [see PDB fi les 3PEV and 3RRM (Dbp5-Gle1-complexes), 1ZSH (dimeric arrestin), 3PEE and 3HO6 ( Clostridium diffi cile protease), 3EEB (cholera toxin protease), 3NTL (glucose 1-phosphatase), 1ZY7 (ADAR, r-RNA specifi c adenosine desaminase)]. In proteins expressed in bacteria, such complexes are not found because bacteria are devoid of InsP 6 . To date, no DPIP was found in protein crystals which, however, may be a consequence of diphosphate group instability upon lengthy crystallizations. Employing hydrolysis resistant DPIPs and routinely trying such compounds in crystallization buffer sets would cope with this ' fi nding ' problem. DPIP concentrations found in yeast and animal cells are much lower than that of InsP 6 (Table 2) . Metal complexation data are not available, but the diphosphate groups are likely to destroy the stable pentamagnesium complex of InsP 6 making it free of net charge towards the outside, i.e., type of ' charge camoufl aged ' . The crystal structures of PPIP5K with bound products and substrates clearly show bound InsP 6 and diphosphorylated products stripped from most Mg 2 + . Hitherto unconsidered, this raises the intriguing possibility that the stripping of InsP 6 from most of its ' charge camoufl age ' by the pyrophosphorylation reaction is the ideal method to liberate a ' visible ' product highly negatively charged and molded into a shape distinct from InsP 6 . Only for a brief period, until magnesium complexes and, in particular, InsP 6 would be formed again, this molecule could specifi cally bind to a complementary multi-cationic surface site or into a corresponding cleft of a target protein or between several basic subpatches of a pre-gathered assembly of proteins, respectively. If so, there is without doubt an absolute need for targeted delivery, directing the producing kinases as close as possible towards the target proteins. By this sequence of events there is a very good chance to have little unspecifi c binding, no precipitation, little waste production due to product diffusing away and thus no need for high amounts of products. The situation would be very similar to the generation of PIP 3 signals in membranes by punctually localized PIP 2 -3-kinases. For such a need for targeted delivery, evolution has long ago invented targeting domains in enzymes and proteins. In fact, all IP3K and IP6K isoforms possess corresponding N-terminal targeting domains, and also PPIP5K and Vip isoforms contain such domains C-terminal from the catalytic domain (Barker et al. , 2009 ; Shears et al. , 2011 ) . With their targeting domains, kinases could also exert functions independent from catalytic activity, but often production of the kinase product and the protein-protein interaction are functionally coupled.
Therefore, searches in the growing ' interactome ' databases for interaction partners should provide information on candidate target proteins of PP-InsP 5 and PP 2 -InsP 4 and also provide a fi rst test of this proposed mechanism of action. We performed such an actual search only for physically interacting proteins. An example of interest from the still small eukarytic interactome with these kinases might be the interaction of PPIP5K1 with CYLD, a probable ubiquitin carboxyl-terminal hydrolase, which is an anti-apoptotic protein. It is involved in the tumor necrosis factor (TNF) receptor driven NF-κ B signaling (Kovalenko and Wallach , 2006 ). An interaction protein of IP6K2, TRAF2 (Morrison et al. , 2007 ) also participates in this anti-apoptotic signaling of TNF receptors. Furthermore, Verbsky and Majerus (2005) showed that increased levels of InsP 6 due to its forced biosynthesis protect HEK293 cells from apoptosis derived by TNF-α and they speculated whether pyrophosphorylated inositols might be responsible for the protection (Verbsky and Majerus , 2005 ) . These data together might indicate a linkage between TNF-α signaling protein components, DPIPs, and their respective kinases. In the well-established, well-controlled, and ' curated ' yeast interactome data, e.g., contained in ' theBiogrid3.1 ' database ( http://thebiogrid.org/ ) or ' IntAct ' from EMBL-EBI ( http:// www.ebi.ac.uk/intact ), we are sure that much more information about important functional targets of the DPIPs will be discovered.
